Cargando…
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
BACKGROUND: Inhibitor of DNA binding/Inhibitor of differentiation 4 (ID4) is a critical factor for cell proliferation and differentiation in normal vertebrate development. ID4 has regulative functions for differentiation and growth of the developing brain. The role of ID1, ID2 and ID3 are expected t...
Autores principales: | Noetzel, Erik, Veeck, Jürgen, Niederacher, Dieter, Galm, Oliver, Horn, Felicitas, Hartmann, Arndt, Knüchel, Ruth, Dahl, Edgar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435120/ https://www.ncbi.nlm.nih.gov/pubmed/18513385 http://dx.doi.org/10.1186/1471-2407-8-154 |
Ejemplares similares
-
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
por: Wiesmann, Frank, et al.
Publicado: (2009) -
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2008) -
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
por: Veeck, Jürgen, et al.
Publicado: (2008) -
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2009) -
The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
por: Bektas, Nuran, et al.
Publicado: (2008)